1. Home
  2. CMT vs PBYI Comparison

CMT vs PBYI Comparison

Compare CMT & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMT
  • PBYI
  • Stock Information
  • Founded
  • CMT 1996
  • PBYI 2010
  • Country
  • CMT United States
  • PBYI United States
  • Employees
  • CMT N/A
  • PBYI N/A
  • Industry
  • CMT Electronic Components
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMT Consumer Discretionary
  • PBYI Health Care
  • Exchange
  • CMT Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • CMT 129.0M
  • PBYI 138.4M
  • IPO Year
  • CMT N/A
  • PBYI N/A
  • Fundamental
  • Price
  • CMT $15.19
  • PBYI $2.86
  • Analyst Decision
  • CMT Strong Buy
  • PBYI Strong Buy
  • Analyst Count
  • CMT 1
  • PBYI 1
  • Target Price
  • CMT $27.00
  • PBYI $7.00
  • AVG Volume (30 Days)
  • CMT 42.5K
  • PBYI 334.3K
  • Earning Date
  • CMT 05-06-2025
  • PBYI 05-01-2025
  • Dividend Yield
  • CMT N/A
  • PBYI N/A
  • EPS Growth
  • CMT N/A
  • PBYI 37.78
  • EPS
  • CMT 1.51
  • PBYI 0.62
  • Revenue
  • CMT $302,378,000.00
  • PBYI $230,468,000.00
  • Revenue This Year
  • CMT N/A
  • PBYI N/A
  • Revenue Next Year
  • CMT N/A
  • PBYI N/A
  • P/E Ratio
  • CMT $10.06
  • PBYI $4.61
  • Revenue Growth
  • CMT N/A
  • PBYI N/A
  • 52 Week Low
  • CMT $12.25
  • PBYI $2.23
  • 52 Week High
  • CMT $21.00
  • PBYI $5.34
  • Technical
  • Relative Strength Index (RSI)
  • CMT 56.44
  • PBYI 42.27
  • Support Level
  • CMT $14.84
  • PBYI $2.83
  • Resistance Level
  • CMT $15.40
  • PBYI $2.99
  • Average True Range (ATR)
  • CMT 0.67
  • PBYI 0.17
  • MACD
  • CMT -0.02
  • PBYI -0.01
  • Stochastic Oscillator
  • CMT 67.04
  • PBYI 50.00

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: